Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Nov;41(11):2562–2565. doi: 10.1128/aac.41.11.2562

Effects of ciprofloxacin and ofloxacin on adult human cartilage in vitro.

M Menschik 1, J Neumüller 1, C W Steiner 1, L Erlacher 1, M Köller 1, R Ullrich 1, W Graninger 1, W B Graninger 1
PMCID: PMC164164  PMID: 9371369

Abstract

Chondrocyte toxicity and necrosis were seen with electron microscopy after incubation of human adult cartilage biopsy specimens in ciprofloxacin or ofloxacin. In vitro exposure of chondrocytes to fluoroquinolones did not affect apoptosis as determined by flow cytometry. While the immediate clinical significance of this finding remains unclear, the possibility of long-term cartilage damage after fluoroquinolone treatment cannot be excluded.

Full Text

The Full Text of this article is available as a PDF (1.7 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bailly S., Fay M., Ferrua B., Gougerot-Pocidalo M. A. Ciprofloxacin treatment in vivo increases the ex vivo capacity of lipopolysaccharide-stimulated human monocytes to produce IL-1, IL-6 and tumour necrosis factor-alpha. Clin Exp Immunol. 1991 Aug;85(2):331–334. doi: 10.1111/j.1365-2249.1991.tb05728.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blanco F. J., Ochs R. L., Schwarz H., Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol. 1995 Jan;146(1):75–85. [PMC free article] [PubMed] [Google Scholar]
  3. Burkhardt J. E., Hill M. A., Carlton W. W. Morphologic and biochemical changes in articular cartilages of immature beagle dogs dosed with difloxacin. Toxicol Pathol. 1992;20(2):246–252. doi: 10.1177/019262339202000211. [DOI] [PubMed] [Google Scholar]
  4. Burkhardt J. E., Hill M. A., Lamar C. H., Smith G. N., Jr, Carlton W. W. Effects of difloxacin on the metabolism of glycosaminoglycans and collagen in organ cultures of articular cartilage. Fundam Appl Toxicol. 1993 Feb;20(2):257–263. doi: 10.1006/faat.1993.1034. [DOI] [PubMed] [Google Scholar]
  5. Burkhardt J. E., Hill M. A., Turek J. J., Carlton W. W. Ultrastructural changes in articular cartilages of immature beagle dogs dosed with difloxacin, a fluoroquinolone. Vet Pathol. 1992 May;29(3):230–238. doi: 10.1177/030098589202900307. [DOI] [PubMed] [Google Scholar]
  6. Danisovicová A., Brezina M., Belan S., Kayserová H., Kaiserová E., Hruskovic I., Orosová K., Dluholucký S., Galova K., Mathéova E. Magnetic resonance imaging in children receiving quinolones: no evidence of quinolone-induced arthropathy. A multicenter survey. Chemotherapy. 1994 May-Jun;40(3):209–214. doi: 10.1159/000239194. [DOI] [PubMed] [Google Scholar]
  7. Gough A. W., Kasali O. B., Sigler R. E., Baragi V. Quinolone arthropathy--acute toxicity to immature articular cartilage. Toxicol Pathol. 1992;20(3 Pt 1):436–450. doi: 10.1177/019262339202000313. [DOI] [PubMed] [Google Scholar]
  8. Hayem G., Petit P. X., Levacher M., Gaudin C., Kahn M. F., Pocidalo J. J. Cytofluorometric analysis of chondrotoxicity of fluoroquinolone antimicrobial agents. Antimicrob Agents Chemother. 1994 Feb;38(2):243–247. doi: 10.1128/aac.38.2.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hildebrand H., Kempka G., Schlüter G., Schmidt M. Chondrotoxicity of quinolones in vivo and in vitro. Arch Toxicol. 1993;67(6):411–415. doi: 10.1007/BF01977402. [DOI] [PubMed] [Google Scholar]
  10. Kato M., Takada S., Ogawara S., Takayama S. Effect of levofloxacin on glycosaminoglycan and DNA synthesis of cultured rabbit chondrocytes at concentrations inducing cartilage lesions in vivo. Antimicrob Agents Chemother. 1995 Sep;39(9):1979–1983. doi: 10.1128/aac.39.9.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kubin R. Safety and efficacy of ciprofloxacin in paediatric patients--review. Infection. 1993 Nov-Dec;21(6):413–421. doi: 10.1007/BF01728929. [DOI] [PubMed] [Google Scholar]
  12. Linseman D. A., Hampton L. A., Branstetter D. G. Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin. Fundam Appl Toxicol. 1995 Nov;28(1):59–64. doi: 10.1006/faat.1995.1146. [DOI] [PubMed] [Google Scholar]
  13. Milio M. C., Campana S. Uso di chinolonici nel trattamento di infezioni da Pseudomonas aeruginosa in bambini con fibrosi cistica. Pediatr Med Chir. 1995 Jan-Feb;17(1):53–55. [PubMed] [Google Scholar]
  14. Mont M. A., Mathur S. K., Frondoza C. G., Hungerford D. S. The effects of ciprofloxacin on human chondrocytes in cell culture. Infection. 1996 Mar-Apr;24(2):151–155. doi: 10.1007/BF01713325. [DOI] [PubMed] [Google Scholar]
  15. Morales T. I., Hascall V. C. Effects of interleukin-1 and lipopolysaccharides on protein and carbohydrate metabolism in bovine articular cartilage organ cultures. Connect Tissue Res. 1989;19(2-4):255–275. doi: 10.3109/03008208909043900. [DOI] [PubMed] [Google Scholar]
  16. Pradhan K. M., Arora N. K., Jena A., Susheela A. K., Bhan M. K. Safety of ciprofloxacin therapy in children: magnetic resonance images, body fluid levels of fluoride and linear growth. Acta Paediatr. 1995 May;84(5):555–560. doi: 10.1111/j.1651-2227.1995.tb13694.x. [DOI] [PubMed] [Google Scholar]
  17. Rusquet R., Bonhommet M., David J. C. Quinolone antibiotics inhibit eucaryotic DNA polymerase alpha and beta, terminal deoxynucleotidyl transferase but not DNA ligase. Biochem Biophys Res Commun. 1984 Jun 29;121(3):762–769. doi: 10.1016/0006-291x(84)90744-7. [DOI] [PubMed] [Google Scholar]
  18. Schaad U. B., Sander E., Wedgwood J., Schaffner T. Morphologic studies for skeletal toxicity after prolonged ciprofloxacin therapy in two juvenile cystic fibrosis patients. Pediatr Infect Dis J. 1992 Dec;11(12):1047–1049. doi: 10.1097/00006454-199211120-00011. [DOI] [PubMed] [Google Scholar]
  19. Schaad U. B., Stoupis C., Wedgwood J., Tschaeppeler H., Vock P. Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin. Pediatr Infect Dis J. 1991 Oct;10(10):723–729. [PubMed] [Google Scholar]
  20. Schaad U. B., Wedgwood J., Ruedeberg A., Kraemer R., Hampel B. Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis. Pediatr Infect Dis J. 1997 Jan;16(1):106–126. doi: 10.1097/00006454-199701000-00032. [DOI] [PubMed] [Google Scholar]
  21. Shakibaei M., Kociok K., Förster C., Vormann J., Günther T., Stahlmann R., Merker H. J. Comparative evaluation of ultrastructural changes in articular cartilage of ofloxacin-treated and magnesium-deficient immature rats. Toxicol Pathol. 1996 Sep-Oct;24(5):580–587. doi: 10.1177/019262339602400507. [DOI] [PubMed] [Google Scholar]
  22. Sharpnack D. D., Mastin J. P., Childress C. P., Henningsen G. M. Quinolone arthropathy in juvenile New Zealand white rabbits. Lab Anim Sci. 1994 Oct;44(5):436–442. [PubMed] [Google Scholar]
  23. Stahlmann R., Förster C., Shakibaei M., Vormann J., Günther T., Merker H. J. Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolone-induced arthropathy. Antimicrob Agents Chemother. 1995 Sep;39(9):2013–2018. doi: 10.1128/aac.39.9.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Stahlmann R., Förster C., Van Sickle D. Quinolones in children. Are concerns over arthropathy justified? Drug Saf. 1993 Dec;9(6):397–403. doi: 10.2165/00002018-199309060-00002. [DOI] [PubMed] [Google Scholar]
  25. Stahlmann R. Knorpelschädigende Wirkung der Chinolone. Infection. 1991;19 (Suppl 1):S38–S46. doi: 10.1007/BF01644734. [DOI] [PubMed] [Google Scholar]
  26. Stahlmann R., Merker H. J., Hinz N., Chahoud I., Webb J., Heger W., Neubert D. Ofloxacin in juvenile non-human primates and rats. Arthropathia and drug plasma concentrations. Arch Toxicol. 1990;64(3):193–204. doi: 10.1007/BF02010725. [DOI] [PubMed] [Google Scholar]
  27. Takada S., Kato M., Takayama S. Comparison of lesions induced by intra-articular injections of quinolones and compounds damaging cartilage components in rat femoral condyles. J Toxicol Environ Health. 1994 May;42(1):73–88. doi: 10.1080/15287399409531864. [DOI] [PubMed] [Google Scholar]
  28. Thuong-Guyot M., Domarle O., Pocidalo J. J., Hayem G. Effects of fluoroquinolones on cultured articular chondrocytes flow cytometric analysis of free radical production. J Pharmacol Exp Ther. 1994 Dec;271(3):1544–1549. [PubMed] [Google Scholar]
  29. Wolfson J. S., Hooper D. C. Overview of fluoroquinolone safety. Am J Med. 1991 Dec 30;91(6A):153S–161S. doi: 10.1016/0002-9343(91)90330-z. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES